{"version":"1.0","provider_name":"Chemi-Pharm","provider_url":"https:\/\/test2.chemi-pharm.com\/et\/","author_name":"Triin","author_url":"https:\/\/test2.chemi-pharm.com\/et\/author\/triin-ch\/","title":"BIOBLOCK TEADUSAJAKIRJAS PLOS ONE - Chemi-Pharm","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"HY1KX1k12M\"><a href=\"https:\/\/test2.chemi-pharm.com\/et\/bioblock-teadusajakirjas-plos-one\/\">BIOBLOCK TEADUSAJAKIRJAS PLOS ONE<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/test2.chemi-pharm.com\/et\/bioblock-teadusajakirjas-plos-one\/embed\/#?secret=HY1KX1k12M\" width=\"600\" height=\"338\" title=\"&#8220;BIOBLOCK TEADUSAJAKIRJAS PLOS ONE&#8221; &#8212; Chemi-Pharm\" data-secret=\"HY1KX1k12M\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/test2.chemi-pharm.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/test2.chemi-pharm.com\/wp-content\/uploads\/2022\/06\/BioBlock-in-PLOS-ONE_landscape2-1920x1080.jpg","thumbnail_width":2560,"thumbnail_height":1440,"description":"Teadusajakiri PLOS ONE avaldas artikli, milles on mahukas info&nbsp;veise ternespiimast p\u00e4rit SARS-CoV-2 vastaste antikehade kohta. Jagatakse andmeid efektiivsusest, ohutusest ja olulisusest meid k\u00f5iki puudutava pandeemia ajal. Infot on kogu kontseptsiooni ja ka v\u00f5imalike rakendusmeetmete kohta, et v\u00e4lja arendada ohutuid ja t\u00f5husaid tooteid, mis oleksid alternatiivseks lisameetmeks viiruse levikuga v\u00f5itlemisel. Palju k\u00f5lapinda ja suurt toetust p\u00e4lvinud [&hellip;]"}